1. Home
  2. ANTX vs AMWL Comparison

ANTX vs AMWL Comparison

Compare ANTX & AMWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

SELL

Current Price

$4.22

Market Cap

172.9M

Sector

Health Care

ML Signal

SELL

Logo American Well Corporation

AMWL

American Well Corporation

SELL

Current Price

$11.18

Market Cap

179.6M

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
ANTX
AMWL
Founded
2017
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
172.9M
179.6M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
ANTX
AMWL
Price
$4.22
$11.18
Analyst Decision
Strong Buy
Hold
Analyst Count
2
7
Target Price
$9.00
★ $13.60
AVG Volume (30 Days)
★ 236.2K
128.1K
Earning Date
11-09-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
32.56
★ 57.06
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.09
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$3.71
52 Week High
$7.19
$15.16

Technical Indicators

Market Signals
Indicator
ANTX
AMWL
Relative Strength Index (RSI) 49.94 37.72
Support Level $3.89 $8.25
Resistance Level $5.11 $13.92
Average True Range (ATR) 0.39 0.98
MACD 0.07 -0.18
Stochastic Oscillator 45.83 1.47

Price Performance

Historical Comparison
ANTX
AMWL

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

About AMWL American Well Corporation

American Well Corp is an enterprise platform and software company digitally enabling hybrid care by offering payers and health systems a technology-enabled care platform. The Amwell Platform, its cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings by enabling critical services like virtual primary care, urgent care, clinical partner programs, scheduling visits, etc. Additionally, the healthcare providers can use the platform to access familiar workflows for taking notes, prescribing, referencing clinical treatment guidelines, and other related activities. The firm also offers various paid services, including licensed clinical staffing, implementation support, workflow design, etc, to help clients execute their hybrid care strategies.

Share on Social Networks: